Ab&B Bio-Tech CO., LTD. JS (HKG:2627)

Hong Kong · Delayed Price · Currency is HKD

29.32

-0.30 (-1.01%)

Mar 31, 2026, 4:08 PM HKT

HKG:2627 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	323.76	259.61	52.17
Revenue Growth	-	397.65%	-
Gross Profit	217.86	151.46	-20.34
Operating Income	-202.7	-256.01	-433.65
Net Income	-224.43	-258.72	-424.74
Earnings Per Share	-0.62	-0.72	-1.18
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	108.43	132.19	77.57
Total Debt	916.49	886.48	421.42
Net Cash (Debt)	-808.07	-754.29	-343.85
Net Cash Growth	-	-	-
Net Cash Per Share	-2.24	-2.10	-0.96

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-123.47	-199.51	-305.99
Capital Expenditures	-105.6	-199.57	-265.3
Free Cash Flow	-229.07	-399.08	-571.29
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	67.29%	58.34%	-39.00%
Operating Margin	-62.61%	-98.61%	-831.25%
Pretax Margin	-69.32%	-99.65%	-814.18%
Profit Margin	-69.32%	-99.66%	-814.18%
FCF Margin	-70.75%	-153.72%	-1095.09%